ClinicalTrials.Veeva

Menu

3D US Guided Femoral Artery Access for TAVI (3D-US-TAVI)

Catharina Hospital logo

Catharina Hospital

Status

Unknown

Conditions

Ultrasound Therapy; Complications
Femoral Artery Injury

Treatments

Device: 3D US
Device: 2D US

Study type

Interventional

Funder types

Other

Identifiers

NCT04691245
3D-US-TAVI

Details and patient eligibility

About

Rationale: Bleeding and vascular complications of the femoral artery still account for significant morbidity and mortality in transcatheter aortic valve implantation procedures. Although steadily declining over the past years through smaller diameter devices and use of ultrasound, major complications still occur in 3-4 % of patients. Femoral access is often obtained using 2D US guidance already. New 3D US probes can aid in increasing anatomical awareness. This can improve first pass success during procedures. Furthermore, for new closure devices, entering the artery at a straight angle at precisely 12 o'clock probably reduces complications. Therefore, the investigators hypothesize improved real time needle guidance using three dimensional ultrasound can decrease procedure related complications.

Enrollment

104 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult age (>18 years)
  • Scheduled to undergo elective transcatheter aortic valve implantation with percutaneous access through the femoral artery
  • Written Informed consent

Exclusion criteria

  • Unable to obtain informed consent
  • Vascular access via alternative approach (radial/subclavian) or surgical cutdown

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

104 participants in 2 patient groups

Intervention
Experimental group
Description:
Femoral access using 3D US
Treatment:
Device: 3D US
Control
Active Comparator group
Description:
Femoral access using 2D US
Treatment:
Device: 2D US

Trial contacts and locations

1

Loading...

Central trial contact

Arthur Bouwman, PhD; Harm Scholten, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems